Development of an LC–MS/MS assay for quantification of intact INSL3 in rat plasma

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Kang L, Weng N, Jian W. LC–MS bioanalysis of intact proteins and peptides. Biomed. Chromatog. 34(1), e4633 (2020). •• Review paper detailing LC–MS bioanalysis for intact peptides (<10 kDa).
  Medline CASGoogle Scholar
• 2. Otvos L Jr, Wade JD. Current challenges in peptide-based drug discovery. Front. Chem. 2, 62 (2014).
  MedlineGoogle Scholar
• 3. Hruby VJ. Designing peptide receptor agonists and antagonists. Nat. Rev. Drug Discov. 1(11), 847–858 (2002).
  Medline CASGoogle Scholar
• 4. Joo SH. Cyclic peptides as therapeutic agents and biochemical tools. Biomol. Ther. (Seoul) 20(1), 19–26 (2012).
  Medline CASGoogle Scholar
• 5. Wang L, Wang N, Zhang W et al. Therapeutic peptides: current applications and future directions. Signal Transduct. Target Ther. 7(1), 48 (2022).
  Medline CASGoogle Scholar
• 6. Di L. Strategic approaches to optimizing peptide ADME properties. APPS J. 17(1), 134–143 (2015).
  Medline CASGoogle Scholar
• 7. Vlieghe P, Lisowski V, Martinez J, Khrestchatisky M. Synthetic therapeutic peptides: science and market. Drug Discov. Today 15(1), 40–56 (2010).
  Medline CASGoogle Scholar
• 8. Chambers EE, Legido-Quigley C, Smith N, Fountain KJ. Development of a fast method for direct analysis of intact synthetic insulins in human plasma: the large peptide challenge. Bioanalysis 5(1), 65–81 (2013).
  CASGoogle Scholar
• 9. Tanna NN, Lame ME, Wrona M. Development of an UPLC/MS–MS method for quantification of intact IGF-I from human serum. Bioanalysis 12(1), 53–65 (2020).
  CASGoogle Scholar
• 10. Kusuma MB, Kashibhatta R, Gavande A et al. Bioanalytical method development and validation of highly selective and sensitive LC–MS/MS method for determination of teriparatide (parathyroid hormone fragment 1–34) in human serum through direct detection of intact teriparatide molecule. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 1187, 123046 (2021).
  Medline CASGoogle Scholar
• 11. Xu Y, Goykhman D, Wang M et al. Strategy for peptide quantification using LC–MS in regulated bioanalysis: case study with a glucose-responsive insulin. Bioanalysis 10(15), 1207–1220 (2018). • Demostrated a case study and strategy for peptide quantification using LC–MS in regulatory bioanalysis.
  CASGoogle Scholar
• 12. Pratt MS, Van Faassen M, Remmelts N, Bischoff R, Kema IP. An antibody-free LC–MS/MS method for the quantification of intact insulin-like growth factors 1 and 2 in human plasma. Anal. Bioanal. Chem. 413(8), 2035–2044 (2021).
  Medline CASGoogle Scholar
• 13. Zha J, Li J, Fan S, Duan Z, Zhao Y, Wu C. An evolution-inspired strategy to design disulfide-rich peptides tolerant to extensive sequence manipulation. Chem. Sci. 12(34), 11464–11472 (2021).
  Medline CASGoogle Scholar
• 14. Anand P, Grigoryan A, Bhuiyan MH et al. Sample limited characterization of a novel disulfide-rich venom peptide toxin from terebrid marine snail Terebra variegata. PLOS ONE 9(4), e94122 (2014).
  MedlineGoogle Scholar
• 15. Albrethsen J, Frederiksen H, Andersson A-M et al. Development and validation of a mass spectrometry-based assay for quantification of insulin-like factor 3 in human serum. Clin. Chem. Lab Med. 56(11), 1913–1920 (2018).
  Medline CASGoogle Scholar
• 16. Smith KJ, Wade JD, Claasz AA et al. Chemical synthesis and biological activity of rat INSL3. J. Pept. Sci. 7(9), 495–501 (2001).
  Medline CASGoogle Scholar
• 17. Anand-Ivell RJK, Relan V, Balvers M et al. Expression of the insulin-like peptide 3 (INSL3) hormone-receptor (LGR8) system in the testis. Biol. Reprod. 74(5), 945–953 (2006).
  Medline CASGoogle Scholar
• 18. Anand-Ivell R, Heng K, Hafen B, Setchell B, Ivell R. Dynamics of INSL3 peptide expression in rodent testis. Biol. Reprod. 81(3), 480–487 (2009).
  Medline CASGoogle Scholar
• 19. Albrethsen J, Juul A, Andersson A-M. Mass spectrometry supports that the structure of circulating human insulin-like factor 3 Is a heterodimer. Front. Endocrinol. 11, 552 (2020). • Presented data that INSL3 heterodimer is present in serum from rodents.
  MedlineGoogle Scholar
• 20. Chen Y, Qiao S, Wang C. Fragmentation of peptides with intra-chain disulfide bonds in triple quadrupole mass spectrometry and its quantitative application to biological samples. Int. J. Mass Sptectrom. 288(1), 68–74 (2009).
  CASGoogle Scholar
• 21. Henninot A, Collins JC, Nuss JM. The current state of peptide drug discovery: back to the future? J. Med. Chem. 61(4), 1382–1414 (2018).
  Medline CASGoogle Scholar